ExoMas S.A.
- Biotech or pharma, therapeutic R&D
Exomas is a preclinical stage biotech company, that develops formulations based on native neural stem cell exosomes capable of preventing and treating neurodegenerative diseases. Exomas promotes neurogenesis and neuroplasticity by stimulating the differentiation of neural stem cells. We have achieved significant results on Parkinsons & Traumatic Brain injury animal models. Recently, we have been elected by Eretz.bio biohealth accelerator from the prestigious Albert Einsteins hospital in Sao Paulo, Brasil.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}